Last SFr.8.21 CHF
Change Today -0.14 / -1.68%
Volume 350.0
As of 11:43 AM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

shl telemedicine ltd-reg (SHLTN) Snapshot

Open
SFr.8.29
Previous Close
SFr.8.35
Day High
SFr.8.29
Day Low
SFr.8.21
52 Week High
05/15/14 - SFr.9.78
52 Week Low
12/13/13 - SFr.6.50
Market Cap
89.3M
Average Volume 10 Days
10.2K
EPS TTM
SFr.0.26
Shares Outstanding
10.9M
EX-Date
09/20/11
P/E TM
35.1x
Dividend
--
Dividend Yield
--
Current Stock Chart for SHL TELEMEDICINE LTD-REG (SHLTN)

Related News

No related news articles were found.

shl telemedicine ltd-reg (SHLTN) Related Businessweek News

No Related Businessweek News Found

shl telemedicine ltd-reg (SHLTN) Details

SHL Telemedicine Ltd., together with its subsidiaries, develops and markets personal telemedicine systems, with a focus on cardiovascular and related diseases to end users and the healthcare community in Israel, Europe, and rest of the world. Its products include smartheart, a personal mobile 12-lead ECG device that enables the detection of heart attacks; CardioSen'C, a cellular-digital 12-lead ECG transmitter that transmits a patient's complete 12-lead ECG and rhythm read-out strip in real-time to support professional evaluation of medical conditions, such as arrhythmia, ischemia, and myocardial infarction; Cardio'B, a portable device, which transmits a 12-lead ECG; and CardioBeeper 12/12 hand-held ECG transmitter device for personal use to transmit their 12-lead ECG in real-time. The company also provides Central Communication Module (CCM), a telecommunication device that transmits medical data to its telemedicine centers from various medical monitoring devices; TeleWeight, a trans-telephonic weight monitoring device for personal use; TelePress, a remote blood pressure monitoring device for personal use; TeleBreather, a remote, electronic, handheld device to test how well the lungs are working; and TelePulse Oximeter, an electronic, handheld diagnostic device to measure the saturation level of oxygen in blood and pulse rate. In addition, it offers telemedicine services that include medical call center services to subscribers utilizing telephonic and Internet communication technology. The company serves subscribing patients, health insurance companies, hospitals, clinics, physicians, and other health care providers. SHL Telemedicine Ltd. was founded in 1987 and is headquartered in Tel Aviv, Israel.

Founded in 1987

shl telemedicine ltd-reg (SHLTN) Top Compensated Officers

Co-Chief Executive Officer and Executive Dire...
Total Annual Compensation: $553.9K
Co-Chief Executive Officer and Executive Dire...
Total Annual Compensation: $545.4K
Chief Technology Officer and Executive Vice P...
Total Annual Compensation: $207.8K
Compensation as of Fiscal Year 2013.

shl telemedicine ltd-reg (SHLTN) Key Developments

SHL Telemedicine Ltd. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended 30 June 2014; Reaffirms Earnings Guidance for 2014

SHL Telemedicine Ltd. reported unaudited consolidated earnings results for the second quarter and six months ended 30 June 2014. The company reported revenue of $10.3 million, EBIT of $0.2 million, EBITDA of $1.7 million, net income of $0.1 million or $0.01 per basic share against revenue of $7.4 million, EBIT of 0.4 million, EBITDA of $1.7 million, net income of $0.0 million or $0.00 per basic share a year ago. Income before taxes on income was $348,000 against $140,000 a year ago. Net cash used in operating activities was $885,000 against $764,000 a year ago. Purchase of property and equipment was $480,000 against $315,000 a year ago. Even with the increased investments in geographical expansion, SHL's financial performance has improved significantly with improved gross and operating results. For the six months, the company reported revenue of $20.9 million, EBIT of $0.6 million, EBITDA of $3.7 million, net income of $0.1 million or $0.01 per basic share against revenue of $14.5 million, EBIT of $0.6 million, EBITDA of $3.1 million, net loss of $0.3 million or $0.03 per basic share a year ago. Income before taxes on income was $663,000 against $6,000 a year ago. Net cash used in operating activities was $3,258,000 against $3,172,000 a year ago. Purchase of property and equipment was $863,000 against $918,000 a year ago. The company confirmed 2014 revenue guidance of over 30% growth year-over-year.

SHL Telemedicine Ltd., Q2 2014 Earnings Call, Aug 20, 2014

SHL Telemedicine Ltd., Q2 2014 Earnings Call, Aug 20, 2014

SHL Telemedicine Ltd. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2014; Provides Earnings Guidance for the Year 2014

SHL Telemedicine Ltd. reported unaudited consolidated earnings results for the first quarter ended March 31, 2014. For the quarter, the company reported revenues of $10,643,000 against $7,140,000 a year ago. Operating income was $366,000 against $178,000 a year ago. Income before taxes on income was $315,000 against loss before taxes on income of $134,000 a year ago. Net income was $3,000 or $0.00 earnings per share against net loss of $345,000 or $0.03 loss per share a year ago. Net cash used in operating activities was $2,373,000 against net cash provided by operating activities of $3,936,000 a year ago. Purchase of property and equipment was $383,000 against $603,000 a year ago. During the first quarter 2014, revenues increased considerably primarily due to the growth in the company's German business, following the acquisition of almeda. Even with the increased investments in geographical expansion, SHL's financial performance has improved significantly with improved gross and operating margins. EBITDA for the quarter amounted to $2.0 million compared with EBITDA of $1.4 million in the first quarter of 2013. Investment in intangible assets was $398,000 against $485,000 a year ago. For the year 2014, the company expects accelerated revenue growth. Increasing revenue outlook to over 30% growth in 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SHLTN:SW SFr.8.21 CHF -0.14

SHLTN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
BioTelemetry Inc $7.32 USD +0.17
LifeWatch AG SFr.9.20 CHF +0.24
View Industry Companies
 

Industry Analysis

SHLTN

Industry Average

Valuation SHLTN Industry Range
No financial data is available for SHLTN.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHL TELEMEDICINE LTD-REG, please visit www.shl-telemedicine.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.